Abstract
Purpose
Imaging features of immune-mediated genitourinary diseases often overlap, and the same disease may manifest in different ways, so understanding imaging findings in the context of the patient’s entire clinical picture is important in providing the correct diagnosis.
Methods
In this article, diseases mediated by the immune system which affect the genitourinary system are reviewed. Examples of immune-mediated genitourinary disease including IgG4-related disease, post-transplant lymphoproliferative disorder, immunodeficiency-associated lymphoproliferative disorder due to immunosuppressive and immunomodulatory medications, lymphoma, leukemia, myeloma, amyloidosis, and histiocytosis.
Results
Clinical and imaging features will be presented which may help narrow the differential diagnosis for each disease.
Conclusion
Recognition of immune-related genitourinary disease is important for appropriate medical management as they may mimic other diseases both by imaging and clinical presentation.
Similar content being viewed by others
Change history
10 May 2019
The original version of this article was published with a error in the initials of the first, fifth and sixth author name: Jonathon Weber, Frank Miller and Jeanne Horowitz. The correct author's initials should be Jonathon D. Weber, Frank H Miller, and Jeanne M Horowitz. It is now corrected with this correction.
References
Hedgire, S.S., et al., The spectrum of IgG4-related disease in the abdomen and pelvis. AJR Am J Roentgenol, 2013. 201(1): p. 14-22
Mann, S., et al., Recognizing IgG4-related tubulointerstitial nephritis. Can J Kidney Health Dis, 2016. 3: p. 34
Della-Torre E, Lanzillotta M., Doglioni C, Immunology of IgG4-related disease. Clin Exp Immunol, 2015. 181(2): p. 191-206
Bledsoe, J.R., et al., IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS, 2018. 126(6): p. 459-476
Stone, J.H., Y. Zen, and V. Deshpande, IgG4-related disease. N Engl J Med, 2012. 366(6): p. 539-51
Saeki, T., et al., The clinical course of patients with IgG4-related kidney disease. Kidney Int, 2013. 84(4): p. 826-33.
Wallace, Z.S., et al., IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol, 2015. 67(9): p. 2466-75
Takahashi, N., et al., Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology, 2007. 242(3): p. 791-801
Kim B, Kim J., Byun JH, et al, IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusionweighted imaging. Eur J Radiol, 2014. 83: p. 1057-1062.
Maruyama S, Sato Y., Taga A, Emoto I, Shirase T, Haga H, Immunoglobulin G4-related disease presenting as bilateral ovarian masses and mimicking advanced ovarian cancer. J Obstet Gynaecol Res, 2016. 42(1): p. 103-8.
Ohkubo, H., et al., A rare case of IgG4-related disease involving the uterus. Rheumatology (Oxford), 2015. 54(6): p. 1124-5
Hara, N., et al., The role of naftopidil in the management of benign prostatic hyperplasia. Ther Adv Urol, 2013. 5(2): p. 111-9
Hara, N., et al., Lower urinary tract symptoms in patients with Niigata Minamata disease: a case-control study 50 years after methyl mercury pollution. Int J Urol, 2013. 20(6): p. 610-5
Migita, K., et al., IgG4-related epididymo-orchitis associated with bladder cancer: possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease. Mod Rheumatol, 2014. 24(1): p. 188-94
Taniguchi, T., et al., A case of multifocal fibrosclerosis involving posterior mediastinal fibrosis, retroperitoneal fibrosis, and a left seminal vesicle with elevated serum IgG4. Hum Pathol, 2006. 37(9): p. 1237-9; author reply 1239.
Zaidan, M., et al., The case mid R: a 69-year-old man with a 10-year history of idiopathic retroperitoneal fibrosis. Kidney Int, 2011. 80(12): p. 1379-80
Opelz, G. and R. Henderson, Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet, 1993. 342(8886-8887): p. 1514-6
Opelz, G. and B. Dohler, Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant, 2004. 4(2): p. 222-30
Bhatia S, Ramsay N., Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, et al, Malignant neoplasms following bone marrow transplantation. Blood, 1996. 87(9): p. 3633-3639.
Cockfield, S.M., Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis, 2001. 3(2): p. 70-8
Loren, A.W., et al., Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant, 2003. 31(3): p. 145-55
McDonald, R.A., et al., Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant, 2008. 8(5): p. 984-9
Shapiro, R., et al., Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation, 1999. 68(12): p. 1851-4.
Dharnidharka, V.R., CComprehensive Review of Post-Organ Transplant Hematologic Cancers. Am J Transplant, 2017
Quinlan, S.C., et al., Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol, 2011. 86(2): p. 206-9
Al-Mansour, Z., B.P. Nelson, and A.M. Evens, Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep, 2013. 8(3): p. 173-83
Katabathina, V., et al., Complications of Immunosuppressive Therapy in Solid Organ Transplantation. Radiol Clin North Am, 2016. 542): p. 303-19
Scarsbrook, A.F., et al., Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol, 2005. 60(1): p. 47-55
Vrachliotis, T.G., et al., CT findings in posttransplantation lymphoproliferative disorder of renal transplants. AJR Am J Roentgenol, 2000. 175(1): p. 183-8
R. Lopez-Ben, J.K.S., C.E. Kew II, et al., Focal posttransplantation lymphoproliferative disorder at renal allograft hilum. AJR Am J Roentgenol, 2000. 175: p. 1417-1422.
Metser, U. and G. Lo, FDG-PET/CT in abdominal post-transplant lymphoproliferative disease. Br J Radiol, 2016. 89(1057): p. 20150844
Barrington, S.F., et al., Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol, 2014. 32(27): p. 3048-58.
Vali R, P.A., Bajno L, Moineddin R, Shammas A., The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis. Pediatr Transplant, 2015. 19(8): p. 932-9.
Vali R, Punnett A., Bajno L, Moineddin R, Shammas A., The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis. Pediatr Transplant, 2015. 19(8): p. 932-9
Inoue T, S. Satoh, Saito M, Horikawa Y, Tsuchiya N, Habuchi T, Post-transplant lymphoproliferative disorder involving the ovary as an initial manifestation: a case report. Journal of Medical Case Reports., 2010(4): p. 184.
Loo, E.Y., et al., Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol, 2013. 37(8): p. 1290-7
Kubica, M.G. and N.A. Sangle, Latrogenic immunodeficiency-associated lymphoproliferative disorders in transplant and nontransplant settings. Indian J Pathol Microbiol, 2016. 59(1): p. 6-15
Kamel OW (1997) Iatrogenic lymphoproliferative disorders in nontransplantation settings. Semin Diagn Pathol 14(1):27–34
Ohkura Y, S.J., Haruta S, et al., Primary Adrenal Lymphoma Possibly Associated With Epstein-Barr Virus Reactivation Due to Immunosuppression Under Methotrexate Therapy. Medicine, 2015. 94(31): p. 1270.
Key Statistics for Non-Hodgkin’s Lymphoma. 2018 [cited 2019 1/4/2019]; Available from: https://www.cancer.org/cancer/non-hodgkin-lymphoma/about/key-statistics.html.
Chen L, Richendollar B., Bunting S, Campbell S, Zhou M., Lymphomas and lymphoproliferative disorders clinically presenting as renal carcinoma: a clinicopathological study of 14 cases. Pathology, 2013. 45(7): p. 756-53.
Sandrasegaran, K., et al., Imaging features of haematological malignancies of kidneys. Clin Radiol, 2016. 71(3): p. 195-202
Bach, A.G., et al., Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseases. Acta Radiol, 2012. 53(3): p. 343-8
Sheth S, Ali S., Fishman E., Imaging of renal lymphoma: patterns of disease with pathologic correlation. Radiographics, 2006. 26(4): p. 1151-1168.
Emad-Eldin S, Rakha S., Hanna AZ, Badawy H, Usefulness of diffusion-weighted magnetic resonance imaging for the characterization of benign and malignant renal lesions. The Egyptian Journal of Radiology and Nuclear Medicine, 2015. 47: p. 325-333.
Dai, Z., et al., Primary follicular non-Hodgkin's lymphoma of the ureter: A case report and literature review. Oncol Lett, 2016. 11(6): p. 3939-3942
Ni, B.W., et al., Malignant lymphoma of the ureter: A case report and literature review. Exp Ther Med, 2014. 7(6): p. 1521-1524
Crasta JA, Vallikad E., Ovarian Lymphoma. Indian J Med Pediatr Oncol, 2009. 30(1): p. 28-30
Zhou, L., et al., Primary adrenal lymphoma: radiological; pathological, clinical correlation. Eur J Radiol, 2012. 81(3): p. 401-5
Thakore P, A.S., Turner C, Vaslyeva T, Acute Lymphocytic Leukemia with Bilateral Renal Masses Masquerading as Nephroblastomatosis. Case reports in pediatrics, 2015. 2015.
Luciano, R.L. and U.C. Brewster, Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis, 2014. 21(1): p. 27-35
Lanore, J.J., et al., Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med, 1991. 19(3): p. 346-51
Richmond, J., et al., Renal lesions associated with malignant lymphomas. Am J Med, 1962. 32: p. 184-207
Araki, T., Leukemic involvement of the kidney in children: CT features. J Comput Assist Tomogr, 1982. 6(4): p. 781-4
Greenstein, F., et al., Ureteral obstruction from isolated focus of chronic lymphocytic leukemia. Urology, 1984. 24(1): p. 70-2
Bogdan, C.A., et al., Chronic lymphocytic leukemia with prostate infiltration mediated by specific clonal membrane-bound IgM. Cancer Res, 2003. 63(9): p. 2067-71
Mazzu, D., R.B. Jeffrey, Jr., and P.W. Ralls, Lymphoma and leukemia involving the testicles: findings on gray-scale and color Doppler sonography. AJR Am J Roentgenol, 1995. 164(3): p. 645-7
Geetha N, Lali V., Mathews A, Prakash NP., Acute lymphoblastic leukaemia presenting with a uterine cervical mass. Clin Cancer Investig J, 2015. 4: p. 280-281.
Oliva E, Ferry J., Young RH, Prat J, Srigley JR, Scully RE, Granulocytic sarcoma of the female genital tract: A clinicopathologic study of 11 cases. Am J Surg Pathol, 1997. 21: p. 1156-65.
Valbuena, J.R., et al., Myeloid sarcoma involving the testis. Am J Clin Pathol, 2005. 124(3): p. 445-52
Zago, L.B., et al., Testicular myeloid sarcoma: case report. Rev Bras Hematol Hemoter, 2013. 35(1): p. 68-70
Rajkumar, S.V., Updated Diagnostic Criteria and Staging System for Multiple Myeloma. Am Soc Clin Oncol Educ Book, 2016. 35: p. e418-23
Oshima, K., et al., Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol, 2001. 67(1): p. 1-5
Philips, S., et al., Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum. J Comput Assist Tomogr, 2012. 36(2): p. 207-12
Kapadia, S.B., Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases. Medicine (Baltimore), 1980. 59(5): p. 380-92
Birjawi, G.A., et al., Abdominal manifestations of multiple myeloma: a retrospective radiologic overview. Clin Lymphoma Myeloma, 2008. 8(6): p. 348-51
IIgel, T.C., et al., Renal plasmacytoma: Mayo Clinic experience and review of the literature. Urology, 1991. 37(4): p. 385-9
Sedlic, A., et al., Abdominal extraosseous lesions of multiple myeloma: imaging findings. Can Assoc Radiol J, 2014. 65(1): p. 2-8
Yang, G. F., Zhu, H., Zhang, L. J., & Lu, G. M, Primary renal plasmacytoma: Case report and literature review. J Cancer Res Exp Oncol., 2009. 2
Sered, S. and P. Nikolaidis, CT findings of perirenal plasmacytoma. AJR Am J Roentgenol, 2003. 181(3): p. 888
Li, Y., et al., Beyond Prostate Adenocarcinoma: Expanding the Differential Diagnosis in Prostate Pathologic Conditions. Radiographics, 2016. 36(4): p. 1055-75
Mimura, R., et al., Extramedullary plasmacytoma involving perirenal space accompanied by extramedullary hematopoiesis and amyloid deposition. Japanese Journal of Radiology, 2010. 28(4): p. 309-13
Jinzaki, M., et al., Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma. International Journal of Urology, 2016. 23(4): p. 284-98
Fitzpatrick, R., et al., Primary amyloidosis of the bladder; a mimicker of bladder cancer. Canadian Journal of Urology, 2017. 24(3): p. 8868-8870
Levine, E., Abdominal visceral calcification in secondary amyloidosis: CT findings. Abdom Imaging, 1994. 19(6): p. 554-5
Kim, B., et al., Imaging of the seminal vesicle and vas deferens. Radiographics, 2009. 29(4): p. 1105-21
Stephens, M., et al., Intense Uptake in Amyloidosis of the Seminal Vesicles on 68Ga-PSMA PET Mimicking Locally Advanced Prostate Cancer. Clinical Nuclear Medicine, 2017. 42(2): p. 147-148
Ogawa, Y., M. Nakagawa, and S. Ikeda, Prostate amyloid tumor is a clue leading to the diagnosis of systemic AL amyloidosis. Amyloid, 2013. 20(3): p. 193-4
Casella, R., et al., Primary testicular amyloidosis mimicking tumor in a cryptorchid testis. Urology, 2002. 59(3): p. 445
Winkler, D.D., J.A. Emery, and C.B. Alan, Amyloidosis of the endometrium: an asymptomatic presentation. Obstetrics & Gynecology, 2004. 104(5 Pt 2): p. 1144-7
Mar, W.A., et al., Rosai–Dorfman Disease: Manifestations Outside of the Head and Neck. AJR Am J Roentgenol, 2017. 208(4): p. 721-732
Brown, W.E., F.V. Coakley, and M. Heaney, Renal involvement by Rosai–Dorfman disease: CT findings. Abdom Imaging, 2002. 27(2): p. 214-6
Rodriguez Torres, C., et al., Rosai–Dorfman disease with atypical intrascrotal involvement. Int J Urol, 2015. 22(8): p. 794-6
Alberti, N., et al., Erdheim–Chester disease: a rare diagnosis with evocative imaging. Diagnostic and Interventional Imaging, 2013. 94(4): p. 457-9
Arnaud, L., et al., Systemic perturbation of cytokine and chemokine networks in Erdheim–Chester disease: a single-center series of 37 patients. Blood, 2011. 117(10): p. 2783-90
Balink, H., et al., Scintigraphic diagnosis of Erdheim–Chester disease. Journal of Clinical Oncology, 2011. 29(16): p. e470-2
Yun, E.J., et al., Erdheim–Chester disease: case report and review of associated urological, radiological and histological features. Journal of Urology, 2003. 169(4): p. 1470-1
Courtillot, C., et al., Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim–Chester Disease. Journal of Clinical Endocrinology & Metabolism, 2016. 101(1): p. 305-13
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Weber, J., Hammond, N., Yaghmai, V. et al. Imaging features of immune-mediated genitourinary disease. Abdom Radiol 44, 2217–2232 (2019). https://doi.org/10.1007/s00261-019-01946-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-019-01946-z